Assembly and regulation of the chlorhexidine-specific efflux pump AceI

Jani Reddy Bolla1, Anna C Howes1, Francesco Fiorentino1

  • 1Physical and Theoretical Chemistry Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3QZ, United Kingdom.

Insights

This study reveals how Acinetobacter baumannii develops resistance to chlorhexidine. Understanding the AceI efflux pump and AceR regulator

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Acinetobacter baumannii is a major cause of hospital-acquired infections.
  • Limited effective antibiotics necessitate understanding resistance mechanisms.
  • The PACE (proteobacterial antimicrobial compound efflux) family mediates resistance, with AceI as a key efflux protein.

Purpose of the Study:

  • To investigate the molecular mechanisms of chlorhexidine resistance in Acinetobacter baumannii.
  • To elucidate the role of the AceI efflux protein and AceR regulator in response to chlorhexidine.
  • To provide insights into the assembly and regulation of PACE family transporters.

Main Methods:

  • Native mass spectrometry was employed to analyze AceI and AceR.
  • The study examined protein oligomerization states under various conditions.
  • The interaction of AceR with DNA and RNA polymerase was investigated.

Main Results:

  • AceI (Acinetobacter chlorhexidine efflux protein I) forms dimers at high pH.
  • Chlorhexidine binding promotes the functional conformation of AceI.
  • Chlorhexidine exposure induced changes in AceR (Acinetobacter chlorhexidine efflux protein regulator) oligomerization, facilitating RNA polymerase-promoter DNA interaction.

Conclusions:

  • The findings illuminate the structural and regulatory mechanisms of PACE transporters.
  • Drug recognition by AceR and AceI is crucial for chlorhexidine resistance.
  • This research suggests potential targets for combating Acinetobacter baumannii infections.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.1K
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.2K
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
5.2K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
225
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
864
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
636